Clonal Expansion during Infection Dynamics Reveals the Effect of Antibiotic Intervention
To slow the inexorable rise of antibiotic resistance we must understand how drugs impact on pathogenesis and influence the selection of resistant clones. Staphylococcus aureus is an important human pathogen with populations of antibiotic-resistant bacteria in hospitals and the community. Host phagocytes play a crucial role in controlling S. aureus infection, which can lead to a population “bottleneck” whereby clonal expansion of a small fraction of the initial inoculum founds a systemic infection. Such population dynamics may have important consequences on the effect of antibiotic intervention. Low doses of antibiotics have been shown to affect in vitro growth and the generation of resistant mutants over the long term, however whether this has any in vivo relevance is unknown. In this work, the population dynamics of S. aureus pathogenesis were studied in vivo using antibiotic-resistant strains constructed in an isogenic background, coupled with systemic models of infection in both the mouse and zebrafish embryo. Murine experiments revealed unexpected and complex bacterial population kinetics arising from clonal expansion during infection in particular organs. We subsequently elucidated the effect of antibiotic intervention within the host using mixed inocula of resistant and sensitive bacteria. Sub-curative tetracycline doses support the preferential expansion of resistant microorganisms, importantly unrelated to effects on growth rate or de novo resistance acquisition. This novel phenomenon is generic, occurring with methicillin-resistant S. aureus (MRSA) in the presence of β-lactams and with the unrelated human pathogen Pseudomonas aeruginosa. The selection of resistant clones at low antibiotic levels can result in a rapid increase in their prevalence under conditions that would previously not be thought to favor them. Our results have key implications for the design of effective treatment regimes to limit the spread of antimicrobial resistance, where inappropriate usage leading to resistance may reduce the efficacy of life-saving drugs.
Vyšlo v časopise:
Clonal Expansion during Infection Dynamics Reveals the Effect of Antibiotic Intervention. PLoS Pathog 10(2): e32767. doi:10.1371/journal.ppat.1003959
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1003959
Souhrn
To slow the inexorable rise of antibiotic resistance we must understand how drugs impact on pathogenesis and influence the selection of resistant clones. Staphylococcus aureus is an important human pathogen with populations of antibiotic-resistant bacteria in hospitals and the community. Host phagocytes play a crucial role in controlling S. aureus infection, which can lead to a population “bottleneck” whereby clonal expansion of a small fraction of the initial inoculum founds a systemic infection. Such population dynamics may have important consequences on the effect of antibiotic intervention. Low doses of antibiotics have been shown to affect in vitro growth and the generation of resistant mutants over the long term, however whether this has any in vivo relevance is unknown. In this work, the population dynamics of S. aureus pathogenesis were studied in vivo using antibiotic-resistant strains constructed in an isogenic background, coupled with systemic models of infection in both the mouse and zebrafish embryo. Murine experiments revealed unexpected and complex bacterial population kinetics arising from clonal expansion during infection in particular organs. We subsequently elucidated the effect of antibiotic intervention within the host using mixed inocula of resistant and sensitive bacteria. Sub-curative tetracycline doses support the preferential expansion of resistant microorganisms, importantly unrelated to effects on growth rate or de novo resistance acquisition. This novel phenomenon is generic, occurring with methicillin-resistant S. aureus (MRSA) in the presence of β-lactams and with the unrelated human pathogen Pseudomonas aeruginosa. The selection of resistant clones at low antibiotic levels can result in a rapid increase in their prevalence under conditions that would previously not be thought to favor them. Our results have key implications for the design of effective treatment regimes to limit the spread of antimicrobial resistance, where inappropriate usage leading to resistance may reduce the efficacy of life-saving drugs.
Zdroje
1. ThwaitesGE, EdgeworthJD, Gkrania-KlotsasE, KirbyA, TilleyR, et al. (2011) Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis 11: 208–222.
2. ChengAG, DeDentAC, SchneewindO, MissiakasD (2011) A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol 19: 225–232.
3. HorstSA, HoerrV, BeinekeA, KreisC, TuchscherrL, et al. (2012) A novel mouse model of Staphylococcus aureus chronic osteomyelitis that closely mimics the human infection: an integrated view of disease pathogenesis. Am J Pathol 181: 1206–1214.
4. HumeEB, ColeN, KhanS, GarthwaiteLL, AliwargaY, et al. (2005) A Staphylococcus aureus mouse keratitis topical infection model: cytokine balance in different strains of mice. Immunol Cell Biol 83: 294–300.
5. PrajsnarTK, HamiltonR, Garcia-LaraJ, McVickerG, WilliamsA, et al. (2012) A privileged intraphagocyte niche is responsible for disseminated infection of Staphylococcus aureus in a zebrafish model. Cell Microbiol 14: 1600–1619.
6. RogersDE, TompsettR (1952) The survival of staphylococci within human leukocytes. J Exp Med 95: 209–230.
7. ThwaitesGE, GantV (2011) Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus? Nat Rev Microbiol 9: 215–222.
8. GreshamHD, LowranceJH, CaverTE, WilsonBS, CheungAL, et al. (2000) Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 164: 3713–3722.
9. GrantAJ, RestifO, McKinleyTJ, SheppardM, MaskellDJ, et al. (2008) Modelling within-host spatiotemporal dynamics of invasive bacterial disease. PLoS Biol 6: e74.
10. PlautRD, KellyVK, LeeGM, StibitzS, MerkelTJ (2012) Dissemination bottleneck in a murine model of inhalational anthrax. Infect Immun 80: 3189–3193.
11. MertensR, SeylerL, LacorP, DenisO (2012) Community associated methicillin-resistant Staphylococcus aureus. Acta Clin Belg 67: 235–240.
12. OtterJA, FrenchGL (2012) Community-associated meticillin-resistant Staphylococcus aureus: the case for a genotypic definition. J Hosp Infect 81: 143–148.
13. LevySB, FitzGeraldGB, MaconeAB (1976) Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm. N Engl J Med 295: 583–588.
14. RinskyJL, NadimpalliM, WingS, HallD, BaronD, et al. (2013) Livestock-associated methicillin and multidrug resistant Staphylococcus aureus is present among industrial, not antibiotic-free livestock operation workers in North Carolina. PLoS One 8: e67641.
15. HandwergerS, TomaszA (1985) Antibiotic tolerance among clinical isolates of bacteria. Annu Rev Pharmacol Toxicol 25: 349–380.
16. Maisnier-PatinS, AnderssonDI (2004) Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res Microbiol 155: 360–369.
17. AnderssonDI, HughesD (2011) Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol Rev 35: 901–911.
18. AnderssonDI, LevinBR (1999) The biological cost of antibiotic resistance. Curr Opin Microbiol 2: 489–493.
19. MasseyRC, BucklingA, PeacockSJ (2001) Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr Biol 11: 1810–1814.
20. TrzcinskiK, CooperBS, HryniewiczW, DowsonCG (2000) Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 45: 763–770.
21. HaoH, DaiM, WangY, HuangL, YuanZ (2012) Key genetic elements and regulation systems in methicillin-resistant Staphylococcus aureus. Future Microbiol 7: 1315–1329.
22. NegriMC, LipsitchM, BlazquezJ, LevinBR, BaqueroF (2000) Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance. Antimicrob Agents Chemother 44: 2485–2491.
23. GullbergE, CaoS, BergOG, IlbackC, SandegrenL, et al. (2011) Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog 7: e1002158.
24. AnderssonDI, HughesD (2012) Evolution of antibiotic resistance at non-lethal drug concentrations. Drug Resist Updat 15: 162–172.
25. PengovA, CeruS (2003) Antimicrobial drug susceptibility of Staphylococcus aureus strains isolated from bovine and ovine mammary glands. J Dairy Sci 86: 3157–3163.
26. HarrisonEM, PatersonGK, HoldenMT, LarsenJ, SteggerM, et al. (2013) Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC. EMBO Mol Med 5: 509–515.
27. JohnsonPJ, LevinBR (2013) Pharmacodynamics, Population Dynamics, and the Evolution of Persistence in Staphylococcus aureus. PLoS Genet 9: e1003123.
28. Abdel HadyW, BayerAS, SeidlK, NastCC, KiedrowskiMR, et al. (2013) Reduced Vancomycin Susceptibility in an in vitro Catheter-Related Biofilm Model Correlates with Poor Therapeutic Outcomes in Experimental Endocarditis due to Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother
29. KjeldgaardJ, CohnMT, CaseyPG, HillC, IngmerH (2012) Residual antibiotics disrupt meat fermentation and increase risk of infection. MBio 3: e00190–00112.
30. NairCG, ChaoC, RyallB, WilliamsHD (2013) Sub-lethal concentrations of antibiotics increase mutation frequency in the cystic fibrosis pathogen Pseudomonas aeruginosa. Lett Appl Microbiol 56: 149–154.
31. DaviesJC, BiltonD (2009) Bugs, biofilms, and resistance in cystic fibrosis. Respir Care 54: 628–640.
32. MainieroM, GoerkeC, GeigerT, GonserC, HerbertS, et al. (2010) Differential target gene activation by the Staphylococcus aureus two-component system saeRS. J Bacteriol 192: 613–623.
33. ChengAG, KimHK, BurtsML, KrauszT, SchneewindO, et al. (2009) Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J 23: 3393–3404.
34. BarnesPD, BergmanMA, MecsasJ, IsbergRR (2006) Yersinia pseudotuberculosis disseminates directly from a replicating bacterial pool in the intestine. J Exp Med 203: 1591–1601.
35. PastarI, NusbaumAG, GilJ, PatelSB, ChenJ, et al. (2013) Interactions of Methicillin Resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in Polymicrobial Wound Infection. PLoS One 8: e56846.
36. ClatworthyAE, LeeJS, LeibmanM, KostunZ, DavidsonAJ, et al. (2009) Pseudomonas aeruginosa infection of zebrafish involves both host and pathogen determinants. Infect Immun 77: 1293–1303.
37. BrannonMK, DavisJM, MathiasJR, HallCJ, EmersonJC, et al. (2009) Pseudomonas aeruginosa Type III secretion system interacts with phagocytes to modulate systemic infection of zebrafish embryos. Cell Microbiol 11: 755–768.
38. RudkinJK, EdwardsAM, BowdenMG, BrownEL, PozziC, et al. (2012) Methicillin resistance reduces the virulence of healthcare-associated methicillin-resistant Staphylococcus aureus by interfering with the agr quorum sensing system. J Infect Dis 205: 798–806.
39. KohanskiMA, DwyerDJ, HayeteB, LawrenceCA, CollinsJJ (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797–810.
40. KerenI, WuY, InocencioJ, MulcahyLR, LewisK (2013) Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339: 1213–1216.
41. LiuY, ImlayJA (2013) Cell death from antibiotics without the involvement of reactive oxygen species. Science 339: 1210–1213.
42. CosgroveK, CouttsG, JonssonIM, TarkowskiA, Kokai-KunJF, et al. (2007) Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus. J Bacteriol 189: 1025–1035.
43. RauchS, DeDentAC, KimHK, Bubeck WardenburgJ, MissiakasDM, et al. (2012) Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection. Infect Immun 80: 3721–3732.
44. von Kockritz-BlickwedeM, RohdeM, OehmckeS, MillerLS, CheungAL, et al. (2008) Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. Am J Pathol 173: 1657–1668.
45. SchweizerML, BossenA, McDanelJS, DennisLK (2012) Staphylococcus aureus colonization before infection is not associated with mortality among S. aureus-infected patients: a meta-analysis. Infect Control Hosp Epidemiol 33: 796–802.
46. RodriguezCA, AgudeloM, ZuluagaAF, VesgaO (2012) Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model. Antimicrob Agents Chemother 56: 243–247.
47. BornsideGH, BornsideBB, CohnIJr (1972) Development of tetracycline-resistant Staphylococcus aureus in gnotobiotic mice. Infect Immun 5: 505–512.
48. PrajsnarTK, CunliffeVT, FosterSJ, RenshawSA (2008) A novel vertebrate model of Staphylococcus aureus infection reveals phagocyte-dependent resistance of zebrafish to non-host specialized pathogens. Cell Microbiol 10: 2312–2325.
49. Grande BurgosMJ, KovacsAT, MironczukAM, AbriouelH, GalvezA, et al. (2009) Response of Bacillus cereus ATCC 14579 to challenges with sublethal concentrations of enterocin AS-48. BMC Microbiol 9: 227.
50. NanduriB, ShackLA, BurgessSC, LawrenceML (2009) The transcriptional response of Pasteurella multocida to three classes of antibiotics. BMC Genomics 10 Suppl 2: S4.
51. PetekM, BaeblerS, KuzmanD, RotterA, PodlesekZ, et al. (2010) Revealing fosfomycin primary effect on Staphylococcus aureus transcriptome: modulation of cell envelope biosynthesis and phosphoenolpyruvate induced starvation. BMC Microbiol 10: 159.
52. HolderD, BerryD, DaiD, RaskinL, XiC (2013) A dynamic and complex monochloramine stress response in Escherichia coli revealed by transcriptome analysis. Water Res 47: 4978–4985.
53. KummererK, HenningerA (2003) Promoting resistance by the emission of antibiotics from hospitals and households into effluent. Clin Microbiol Infect 9: 1203–1214.
54. ChanderY, KumarK, GoyalSM, GuptaSC (2005) Antibacterial activity of soil-bound antibiotics. J Environ Qual 34: 1952–1957.
55. ReadAF, DayT, HuijbenS (2011) The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proc Natl Acad Sci U S A 108 Suppl 2: 10871–10877.
56. LawV, KnoxC, DjoumbouY, JewisonT, GuoAC, et al. (2013) DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res
57. VagnerV, DervynE, EhrlichSD (1998) A vector for systematic gene inactivation in Bacillus subtilis. Microbiology 144 (Pt 11) 3097–3104.
58. Aish J (2003) Environmental regulation of virulence determinant expression in Staphylococcus aureus. Dissertation. University of Sheffield, Sheffield, United Kingdom.
59. CooperEL, Garcia-LaraJ, FosterSJ (2009) YsxC, an essential protein in Staphylococcus aureus crucial for ribosome assembly/stability. BMC Microbiol 9: 266.
60. ChoiKH, SchweizerHP (2006) mini-Tn7 insertion in bacteria with single attTn7 sites: example Pseudomonas aeruginosa. Nat Protoc 1: 153–161.
61. Nüsslein-Volhard C, Dahm R (2002) Zebrafish: a practical approach. New York: Oxford University Press. 303 p.
62. RhodesJ, HagenA, HsuK, DengM, LiuTX, et al. (2005) Interplay of Pu.1 and Gata1 determines myelo-erythroid progenitor cell fate in zebrafish. Dev Cell 8: 97–108.
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2014 Číslo 2
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Lundep, a Sand Fly Salivary Endonuclease Increases Parasite Survival in Neutrophils and Inhibits XIIa Contact Activation in Human Plasma
- Reversible Silencing of Cytomegalovirus Genomes by Type I Interferon Governs Virus Latency
- Implication of PMLIV in Both Intrinsic and Innate Immunity
- Male-Killing Induces Sex-Specific Cell Death via Host Apoptotic Pathway